| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TCON | Tracon Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director | $54.2K | Mar 12, 2024 | ||
| FDMT | 4D Molecular Therapeutics, Inc. | Director | Jun 17, 2025 | |||
| ONCT | Oncternal Therapeutics, Inc. | Director | Jun 20, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|